Found: 51
Select item for more details and to access through your institution.
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 12, p. 3219, doi. 10.1007/s00520-014-2328-7
- By:
- Publication type:
- Article
Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare.
- Published in:
- BJU International, 2016, v. 118, n. 6, p. 880, doi. 10.1111/bju.13483
- By:
- Publication type:
- Article
Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.697955
- By:
- Publication type:
- Article
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 2, p. 219, doi. 10.15252/emmm.201707689
- By:
- Publication type:
- Article
A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in mice.
- Published in:
- Microbiology & Immunology, 2013, v. 57, n. 12, p. 833, doi. 10.1111/1348-0421.12100
- By:
- Publication type:
- Article
The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy.
- Published in:
- Journal of Surgical Oncology, 2014, v. 110, n. 4, p. 476, doi. 10.1002/jso.23677
- By:
- Publication type:
- Article
IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 1, p. 246, doi. 10.1002/eji.201040773
- By:
- Publication type:
- Article
The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 3, p. 495, doi. 10.1007/s00432-014-1828-7
- By:
- Publication type:
- Article
Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer.
- Published in:
- Andrologia, 2019, v. 51, n. 9, p. N.PAG, doi. 10.1111/and.13354
- By:
- Publication type:
- Article
Serum testosterone before and during androgen‐deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer.
- Published in:
- Andrologia, 2018, v. 50, n. 10, p. N.PAG, doi. 10.1111/and.13119
- By:
- Publication type:
- Article
The Oncological Outcomes and Risk Stratification in Docetaxel Chemotherapy for Castration-resistant Prostate Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 9, p. 860, doi. 10.1093/jjco/hyu081
- By:
- Publication type:
- Article
The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 5, p. 1443, doi. 10.1245/s10434-016-5705-2
- By:
- Publication type:
- Article
Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 727, doi. 10.1007/s00262-021-03032-0
- By:
- Publication type:
- Article
Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1155, doi. 10.1007/s00262-020-02533-8
- By:
- Publication type:
- Article
YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 517, doi. 10.1007/s00262-012-1356-8
- By:
- Publication type:
- Article
Editorial Comment to Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma.
- Published in:
- IJU Case Reports, 2020, v. 3, n. 5, p. 179, doi. 10.1002/iju5.12181
- By:
- Publication type:
- Article
Current status and future perspectives of immunotherapy against urothelial and kidney cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 10, p. 1481, doi. 10.1093/jjco/hyab121
- By:
- Publication type:
- Article
Prognostic impact of prior local therapy in castration-resistant prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1142, doi. 10.1093/jjco/hyab019
- By:
- Publication type:
- Article
External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 810, doi. 10.1093/jjco/hyaa264
- By:
- Publication type:
- Article
Overview of current and future systemic therapy for metastatic renal cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 5, p. 395, doi. 10.1093/jjco/hyz013
- By:
- Publication type:
- Article
Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 5, p. 453, doi. 10.1093/jjco/hyx013
- By:
- Publication type:
- Article
Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 10, p. 952, doi. 10.1093/jjco/hyw098
- By:
- Publication type:
- Article
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1557, doi. 10.1007/s00280-011-1660-6
- By:
- Publication type:
- Article
Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2019.03138
- By:
- Publication type:
- Article
Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells.
- Published in:
- Oncology Reports, 2015, v. 33, n. 6, p. 2947, doi. 10.3892/or.2015.3893
- By:
- Publication type:
- Article
High‐throughput screen identifies 5‐HT receptor as a modulator of AR and a therapeutic target for prostate cancer.
- Published in:
- Prostate, 2020, v. 80, n. 11, p. 885, doi. 10.1002/pros.24022
- By:
- Publication type:
- Article
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1147, doi. 10.1002/pros.23828
- By:
- Publication type:
- Article
Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide.
- Published in:
- Prostate, 2018, v. 78, n. 14, p. 1045, doi. 10.1002/pros.23661
- By:
- Publication type:
- Article
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.
- Published in:
- Prostate, 2017, v. 77, n. 3, p. 309, doi. 10.1002/pros.23269
- By:
- Publication type:
- Article
Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 959, doi. 10.1002/pros.22813
- By:
- Publication type:
- Article
Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 8, p. 829, doi. 10.1002/pros.22799
- By:
- Publication type:
- Article
Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1, and androgen receptor.
- Published in:
- Prostate, 2013, v. 73, n. 12, p. 1336, doi. 10.1002/pros.22681
- By:
- Publication type:
- Article
Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells.
- Published in:
- Prostate, 2011, v. 71, n. 3, p. 298, doi. 10.1002/pros.21243
- By:
- Publication type:
- Article
Clinical factors affecting perioperative outcomes in robot-assisted radical prostatectomy.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 9, n. 5, p. 575, doi. 10.3892/mco.2018.1718
- By:
- Publication type:
- Article
A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 8, n. 6, p. 785, doi. 10.3892/mco.2018.1602
- By:
- Publication type:
- Article
Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up results of a clinical chart review.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 9, p. 762, doi. 10.1111/iju.15206
- By:
- Publication type:
- Article
Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 10, p. 1155, doi. 10.1111/iju.14953
- By:
- Publication type:
- Article
Validation of models predicting lymph node involvement probability in patients with prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 5, p. 428, doi. 10.1111/iju.14802
- By:
- Publication type:
- Article
Predictive factors of survival outcomes in first‐line therapy for metastatic castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 1, p. 26, doi. 10.1111/iju.14702
- By:
- Publication type:
- Article
Clinical advantages of robot‐assisted partial nephrectomy versus laparoscopic partial nephrectomy in terms of global and split renal functions: A propensity score‐matched comparative analysis.
- Published in:
- International Journal of Urology, 2021, v. 28, n. 6, p. 630, doi. 10.1111/iju.14525
- By:
- Publication type:
- Article
Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide.
- Published in:
- International Journal of Urology, 2020, v. 27, n. 12, p. 1109, doi. 10.1111/iju.14366
- By:
- Publication type:
- Article
Cyclophosphamide‐induced tolerance in kidney transplantation avoids long‐term immunosuppressive therapy.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 2, p. 112, doi. 10.1111/iju.13474
- By:
- Publication type:
- Article
Impact of Cold and Warm Ischemia on Postoperative Recovery of Affected Renal Function After Partial Nephrectomy.
- Published in:
- Journal of Endourology, 2011, v. 25, n. 5, p. 869, doi. 10.1089/end.2010.0502
- By:
- Publication type:
- Article
A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 2, p. 365, doi. 10.1002/ijc.26009
- By:
- Publication type:
- Article
Gene amplification of YB‐1 in castration‐resistant prostate cancer in association with aberrant androgen receptor expression.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 323, doi. 10.1111/cas.14695
- By:
- Publication type:
- Article
Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 7, p. 2460, doi. 10.1111/cas.14449
- By:
- Publication type:
- Article
Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants.
- Published in:
- Cancer Science, 2018, v. 109, n. 10, p. 3224, doi. 10.1111/cas.13751
- By:
- Publication type:
- Article
Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2.
- Published in:
- Cancer Science, 2016, v. 107, n. 7, p. 1022, doi. 10.1111/cas.12948
- By:
- Publication type:
- Article